Implant prequalified by WHO
29th September 2009
Better known by its brand name, Jadelle, the 2 rod (75 mg each) hormonal implant manufactured by Bayer Schering Pharma is the newest reproductive health product to be prequalified by the World Health Organization.
The Jadelle implant joins the two oral contraceptive pills prequalified by WHO earlier this year on the list of prequalified reproductive health medicines. For the latest list of prequalified reproductive health products, please click here.